1. Home
  2. IDT vs NRIX Comparison

IDT vs NRIX Comparison

Compare IDT & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDT
  • NRIX
  • Stock Information
  • Founded
  • IDT 1990
  • NRIX 2009
  • Country
  • IDT United States
  • NRIX United States
  • Employees
  • IDT N/A
  • NRIX N/A
  • Industry
  • IDT Telecommunications Equipment
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IDT Telecommunications
  • NRIX Health Care
  • Exchange
  • IDT Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • IDT 1.3B
  • NRIX 1.1B
  • IPO Year
  • IDT 1996
  • NRIX 2020
  • Fundamental
  • Price
  • IDT $52.21
  • NRIX $11.38
  • Analyst Decision
  • IDT
  • NRIX Strong Buy
  • Analyst Count
  • IDT 0
  • NRIX 17
  • Target Price
  • IDT N/A
  • NRIX $30.82
  • AVG Volume (30 Days)
  • IDT 149.8K
  • NRIX 980.6K
  • Earning Date
  • IDT 03-06-2025
  • NRIX 04-14-2025
  • Dividend Yield
  • IDT 0.46%
  • NRIX N/A
  • EPS Growth
  • IDT 117.30
  • NRIX N/A
  • EPS
  • IDT 3.15
  • NRIX N/A
  • Revenue
  • IDT $1,221,391,000.00
  • NRIX $54,549,000.00
  • Revenue This Year
  • IDT N/A
  • NRIX N/A
  • Revenue Next Year
  • IDT N/A
  • NRIX $3.20
  • P/E Ratio
  • IDT $16.71
  • NRIX N/A
  • Revenue Growth
  • IDT 1.75
  • NRIX N/A
  • 52 Week Low
  • IDT $33.84
  • NRIX $10.21
  • 52 Week High
  • IDT $58.77
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • IDT 59.32
  • NRIX 32.85
  • Support Level
  • IDT $50.55
  • NRIX $12.20
  • Resistance Level
  • IDT $53.00
  • NRIX $13.10
  • Average True Range (ATR)
  • IDT 1.58
  • NRIX 0.79
  • MACD
  • IDT 0.17
  • NRIX -0.09
  • Stochastic Oscillator
  • IDT 82.71
  • NRIX 26.71

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: